adibendan has been researched along with Heart Failure in 4 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
England, PJ; Murray, KJ | 1 |
Dietz, R; Haass, M; Kapp, M; Kübler, W; Neumann, FJ; Rauch, B; Smolarz, A; Tillmanns, H; Von Molitor, S; Zimmermann, R | 1 |
May, E; Peters, P; Saborowski, F; Schneider, M | 1 |
Karsch, KR; Mauser, M; Preisack, M; Voelker, W | 1 |
1 review(s) available for adibendan and Heart Failure
Article | Year |
---|---|
Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Benzimidazoles; Dihydropyridines; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoenzymes; Milrinone; Oxindoles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Vasodilator Agents | 1992 |
3 other study(ies) available for adibendan and Heart Failure
Article | Year |
---|---|
Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
Topics: Adult; Benzimidazoles; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Male; Middle Aged; Neurosecretory Systems; Oxindoles; Phosphodiesterase Inhibitors | 1991 |
[Central hemodynamics of a new positive inotropic substance, adibendan. Data from a dose-finding study].
Topics: Aged; Benzimidazoles; Blood Pressure; Cardiac Output; Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxindoles; Pulmonary Circulation; Stroke Volume; Vasodilator Agents | 1990 |
Acute hemodynamic effects of adibendan, a new phosphodiesterase inhibitor, for severe congestive heart failure.
Topics: Benzimidazoles; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxindoles; Phosphodiesterase Inhibitors; Random Allocation; Vasodilator Agents | 1989 |